Rating Change
Cantor Fitzgerald analysts reiterated a Overweight rating on Gilead Sciences, Inc. (NASDAQ:GILD) on August 05, 2026.
reiterateNASDAQ:GILD
Cantor Fitzgerald Reiterates Overweight Rating on Gilead Sciences, Inc. (GILD)
Rating Change Cantor Fitzgerald analysts reiterated a Overweight rating on Gilead Sciences, Inc. (NASDAQ:GILD) on August 05, 2026. Market Context Gilead Sciences, Inc.
Market Context
Gilead Sciences, Inc. operates in the Healthcare sector. The stock currently trades at $131.76 with a market capitalization of $152.9B. The stock has gained 5.4% over the past 52 weeks.
Analyst coverage from Cantor Fitzgerald provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Gilead Sciences, Inc..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Gilead Sciences, Inc.
Among the 10 most recent ratings: 6 Buy, 4 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 05, 2026 | RBC Capital | Sector Perform | N/A |
| Aug 05, 2026 | Cantor Fitzgerald | Overweight | N/A |
| Aug 05, 2026 | Needham | Buy | N/A |
| Jul 29, 2026 | Barclays | Equal-Weight | N/A |
| Jul 27, 2026 | Morgan Stanley | Overweight | N/A |
Related Tools: Analyst Ratings Dashboard | View GILD Stock Page
Frequently Asked Questions
What does a Overweight rating mean for GILD?
A Overweight rating from Cantor Fitzgerald reflects the analyst's outlook on Gilead Sciences, Inc. (NASDAQ:GILD). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the GILD forecast page.